OSPHENA (ospemifene) Duchesnay Patent: 9,566,252 Expiration: Nov 2, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of October 30, 2022 Read Post »
OSPHENA (ospemifene) Duchesnay Patent: 9,566,252 Expiration: Nov 2, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of October 30, 2022 Read Post »
This chart shows the pharmaceutical companies with patents in the most countries. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the greatest glo…
Which pharmaceutical companies have the greatest global patent coverage? Read Post »
Annual Drug Patent Expirations for OSPHENA Osphena is a drug marketed by Duchesnay and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent expiration for Duchesnay drug OSPHENA appeared fir…
New patent expiration for Duchesnay drug OSPHENA Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
This chart shows the pharmaceutical companies with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Croatia? Read Post »
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. There are nine patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugP…
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
Get new actionable insights and updates from BiotechBlog
